Earnings Call · Q2 FY2022·2022-08-15

Q2 22EPS -36.06%·Rev n/aQ1 22EPS -15.99%·Rev n/aQ4 21EPS -2.83%·Rev n/aQ3 21EPS +4.40%·Rev n/a⚠ consensus missing

DarioHealth Corp. DRIO

Glenn Garmont — Investor Relations

Erez Raphael — Chief Executive Officer

Richard Anderson — President

−5.9%1d on move date−6.3% vs SPY3d−23.3%5d−31.6%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more DRIO calls or request research access.

More DRIO calls Browse calls Request research access